Macquarie Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-62,875
| Closed | -$9.16M | – | 2579 |
|
|
2022
Q2 | $9.16M | Sell |
62,875
-690,008
| -92% | -$101M | 0.01% | 887 |
|
|
2022
Q1 | $89.3K | Buy |
752,883
+14,684
| +2% | +$1.74K | 0.07% | 328 |
|
|
2021
Q4 | $102M | Buy |
738,199
+218,075
| +42% | +$30.1M | 0.08% | 300 |
|
|
2021
Q3 | $72.3M | Buy |
520,124
+518,251
| +27,670% | +$72M | 0.06% | 413 |
|
|
2021
Q2 | $182K | Sell |
1,873
-72
| -4% | -$7K | ﹤0.01% | 1822 |
|
|
2021
Q1 | $133K | Sell |
1,945
-453
| -19% | -$31K | ﹤0.01% | 1824 |
|
|
2020
Q4 | $206K | Hold |
2,398
| – | – | ﹤0.01% | 1654 |
|
|
2020
Q3 | $156K | Hold |
2,398
| – | – | ﹤0.01% | 1674 |
|
|
2020
Q2 | $175K | Buy |
2,398
+1,298
| +118% | +$94.7K | ﹤0.01% | 1588 |
|
|
2020
Q1 | $37K | Hold |
1,100
| – | – | ﹤0.01% | 1846 |
|
|
2019
Q4 | $60K | Buy |
+1,100
| New | +$60K | ﹤0.01% | 1840 |
|